STAAR Surgical Company (STAA)
$21.67-3.17%Close
BUYRECOVERY · day 9
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $1.1B
- Beta
- 1.22
- P/E (TTM)
- 276.87
- Short % float
- 7.57%
- Days to cover
- 2.8
- SI change
- -19.3%
- 1W
- -3.56%
- 1M
- -7.47%
- vs SPY 1W
- -4.72%
- vs SPY 1M
- -10.46%
Industry peers
FMP comparable companies · ranked by market cap
- TERNTerns Pharmaceuticals, Inc.$4.8B$52.95
- PLSESELLPulse Biosciences, Inc.$3.3BBULLQ 27$47.90+7.66%
- PGENBUYPrecigen, Inc.$3.0BBULLQ 10$8.54+2.76%
- BLFSBUYBioLife Solutions, Inc.$1.8BBULLQ 11$37.30+0.00%
- AZTABUYAzenta, Inc.$1.8BRECOVERYQ 9$38.75+4.78%
- NVCRSELLNovocure Ltd$1.7BCRISISQ 11$14.94+2.53%
- KMTSBUYKestra Medical Technologies, Ltd.$1.6BBEARQ 23$27.43+4.70%
- ORICSELLORIC Pharmaceuticals, Inc.$1.3BBEARQ 3$12.21-0.33%
- TRMLTourmaline Bio, Inc.$1.2B$47.98
- BBNXSELLBeta Bionics, Inc.$853MCRISISQ -6$18.96+1.15%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on STAA?
- LOPJLB’s latest quantitative signal on STAAR Surgical Company (STAA) is BUY in a RECOVERY regime. Signals are updated daily.
- What market regime is STAA in?
- STAAR Surgical Company (STAA) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does STAAR Surgical Company (STAA) do?
- STAAR Surgical Company, along with its subsidiaries, specializes in ophthalmological solutions, focusing on the design, development, manufacturing, and commercialization of implantable lenses for vision correction, complete with the sophisticated delivery systems necessary for their implantation. A core offering is the Visian implantable Collamer lens (ICL) product line, designed to correct var…